Clinical Trial Update: Ropivacaine Pharmacokinetics After Erector Spinae Block [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating pharmacokinetics of ropivacaine after erector spinae block for pain related to spinal fusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Spinal Fusion

Drugs mentioned

• Ropivacaine (Ropivacaine)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Pain, Spinal Fusion | Phase 4 | Status: UNKNOWN